QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 251 filers reported holding QIAGEN NV in Q4 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,039,094 | +552.6% | 50,348 | +625.6% | 0.14% | +585.0% |
Q2 2023 | $312,463 | -89.7% | 6,939 | -90.6% | 0.02% | -91.3% |
Q3 2022 | $3,037,000 | +4.1% | 73,592 | +19.0% | 0.23% | -14.6% |
Q2 2022 | $2,918,000 | +102.9% | 61,836 | +110.7% | 0.27% | +114.4% |
Q1 2022 | $1,438,000 | -7.1% | 29,352 | -8.3% | 0.12% | +2.5% |
Q2 2021 | $1,548,000 | +81.1% | 32,009 | +82.3% | 0.12% | +50.6% |
Q1 2021 | $855,000 | +20.1% | 17,561 | +28.9% | 0.08% | -1.2% |
Q3 2020 | $712,000 | +48.0% | 13,628 | +21.1% | 0.08% | +28.1% |
Q2 2020 | $481,000 | +479.5% | 11,255 | +352.9% | 0.06% | +700.0% |
Q4 2019 | $83,000 | -95.0% | 2,485 | -95.1% | 0.01% | -95.1% |
Q3 2019 | $1,666,000 | +98.8% | 50,535 | +128.4% | 0.16% | +178.0% |
Q3 2018 | $838,000 | +698.1% | 22,124 | +575.5% | 0.06% | +555.6% |
Q1 2018 | $105,000 | -94.5% | 3,275 | -94.7% | 0.01% | -94.9% |
Q4 2017 | $1,919,000 | +83.5% | 62,045 | +86.7% | 0.18% | +78.0% |
Q3 2017 | $1,046,000 | +159.6% | 33,231 | +176.3% | 0.10% | +163.2% |
Q2 2017 | $403,000 | +690.2% | 12,026 | +574.1% | 0.04% | +660.0% |
Q1 2017 | $51,000 | – | 1,784 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |